Selected research
Industry Research
Finasteride Preparations Industry Research Report 2026
Market perspective
The global Finasteride Preparations market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Finasteride Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Finasteride Preparations is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Finasteride Preparations is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Finasteride Preparations include Zhejiang Xianju Pharmaceutical, Grand Pharmaceutical, Topfond Pharmaceutical, Shanghai Shyndec Pharmaceutical, Humanwell Pharmaceutical, Zhejiang Conba Pharmaceutical, CR Double-Crane, Zydus and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Finasteride Preparations market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Finasteride Preparations Market by Company
Zhejiang Xianju Pharmaceutical
Grand Pharmaceutical
Topfond Pharmaceutical
Shanghai Shyndec Pharmaceutical
Humanwell Pharmaceutical
Zhejiang Conba Pharmaceutical
CR Double-Crane
Zydus
Teva
Sun Pharma
Organon
Hetero
Dr. Reddy's Laboratories
Aurobindo Pharma
Alkem
Accord Healthcare
Finasteride Preparations Segment by Type
Capsules
Tablets
Finasteride Preparations Segment by Application
Male Pattern Baldness
Benign Prostatic Hyperplasia (BPH)
Other
Finasteride Preparations Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Finasteride Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride Preparations.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Finasteride Preparations manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Finasteride Preparations by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Finasteride Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules
- Tablets
Applications
- Male Pattern Baldness
- Benign Prostatic Hyperplasia (BPH)
- Other
Companies covered
- Zhejiang Xianju Pharmaceutical
- Grand Pharmaceutical
- Topfond Pharmaceutical
- Shanghai Shyndec Pharmaceutical
- Humanwell Pharmaceutical
- Zhejiang Conba Pharmaceutical
- CR Double-Crane
- Zydus
- Teva
- Sun Pharma
- Organon
- Hetero
- Dr. Reddy's Laboratories
- Aurobindo Pharma
- Alkem
- Accord Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Finasteride Preparations Market Size (2021-2032)
- 2.2.2 Global Finasteride Preparations Sales (2021-2032)
- 2.2.3 Global Finasteride Preparations Market Average Price (2021-2032)
- 2.3 Finasteride Preparations by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsules
- 2.3.3 Tablets
- 2.4 Finasteride Preparations by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Male Pattern Baldness
- 2.4.3 Benign Prostatic Hyperplasia (BPH)
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Finasteride Preparations Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Finasteride Preparations Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Finasteride Preparations Revenue of Manufacturers (2021-2026)
- 3.4 Global Finasteride Preparations Average Price by Manufacturers (2021-2026)
- 3.5 Global Finasteride Preparations Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Finasteride Preparations, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Finasteride Preparations, Product Type & Application
- 3.8 Global Manufacturers of Finasteride Preparations, Established Date
- 3.9 Global Finasteride Preparations Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Xianju Pharmaceutical
- 4.1.1 Zhejiang Xianju Pharmaceutical Company Information
- 4.1.2 Zhejiang Xianju Pharmaceutical Business Overview
- 4.1.3 Zhejiang Xianju Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Xianju Pharmaceutical Finasteride Preparations Product Portfolio
- 4.1.5 Zhejiang Xianju Pharmaceutical Recent Developments
- 4.2 Grand Pharmaceutical
- 4.2.1 Grand Pharmaceutical Company Information
- 4.2.2 Grand Pharmaceutical Business Overview
- 4.2.3 Grand Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Grand Pharmaceutical Finasteride Preparations Product Portfolio
- 4.2.5 Grand Pharmaceutical Recent Developments
- 4.3 Topfond Pharmaceutical
- 4.3.1 Topfond Pharmaceutical Company Information
- 4.3.2 Topfond Pharmaceutical Business Overview
- 4.3.3 Topfond Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Topfond Pharmaceutical Finasteride Preparations Product Portfolio
- 4.3.5 Topfond Pharmaceutical Recent Developments
- 4.4 Shanghai Shyndec Pharmaceutical
- 4.4.1 Shanghai Shyndec Pharmaceutical Company Information
- 4.4.2 Shanghai Shyndec Pharmaceutical Business Overview
- 4.4.3 Shanghai Shyndec Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shanghai Shyndec Pharmaceutical Finasteride Preparations Product Portfolio
- 4.4.5 Shanghai Shyndec Pharmaceutical Recent Developments
- 4.5 Humanwell Pharmaceutical
- 4.5.1 Humanwell Pharmaceutical Company Information
- 4.5.2 Humanwell Pharmaceutical Business Overview
- 4.5.3 Humanwell Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Humanwell Pharmaceutical Finasteride Preparations Product Portfolio
- 4.5.5 Humanwell Pharmaceutical Recent Developments
- 4.6 Zhejiang Conba Pharmaceutical
- 4.6.1 Zhejiang Conba Pharmaceutical Company Information
- 4.6.2 Zhejiang Conba Pharmaceutical Business Overview
- 4.6.3 Zhejiang Conba Pharmaceutical Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zhejiang Conba Pharmaceutical Finasteride Preparations Product Portfolio
- 4.6.5 Zhejiang Conba Pharmaceutical Recent Developments
- 4.7 CR Double-Crane
- 4.7.1 CR Double-Crane Company Information
- 4.7.2 CR Double-Crane Business Overview
- 4.7.3 CR Double-Crane Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CR Double-Crane Finasteride Preparations Product Portfolio
- 4.7.5 CR Double-Crane Recent Developments
- 4.8 Zydus
- 4.8.1 Zydus Company Information
- 4.8.2 Zydus Business Overview
- 4.8.3 Zydus Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Zydus Finasteride Preparations Product Portfolio
- 4.8.5 Zydus Recent Developments
- 4.9 Teva
- 4.9.1 Teva Company Information
- 4.9.2 Teva Business Overview
- 4.9.3 Teva Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teva Finasteride Preparations Product Portfolio
- 4.9.5 Teva Recent Developments
- 4.10 Sun Pharma
- 4.10.1 Sun Pharma Company Information
- 4.10.2 Sun Pharma Business Overview
- 4.10.3 Sun Pharma Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sun Pharma Finasteride Preparations Product Portfolio
- 4.10.5 Sun Pharma Recent Developments
- 4.11 Organon
- 4.11.1 Organon Company Information
- 4.11.2 Organon Business Overview
- 4.11.3 Organon Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Organon Finasteride Preparations Product Portfolio
- 4.11.5 Organon Recent Developments
- 4.12 Hetero
- 4.12.1 Hetero Company Information
- 4.12.2 Hetero Business Overview
- 4.12.3 Hetero Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hetero Finasteride Preparations Product Portfolio
- 4.12.5 Hetero Recent Developments
- 4.13 Dr. Reddy's Laboratories
- 4.13.1 Dr. Reddy's Laboratories Company Information
- 4.13.2 Dr. Reddy's Laboratories Business Overview
- 4.13.3 Dr. Reddy's Laboratories Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Dr. Reddy's Laboratories Finasteride Preparations Product Portfolio
- 4.13.5 Dr. Reddy's Laboratories Recent Developments
- 4.14 Aurobindo Pharma
- 4.14.1 Aurobindo Pharma Company Information
- 4.14.2 Aurobindo Pharma Business Overview
- 4.14.3 Aurobindo Pharma Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Aurobindo Pharma Finasteride Preparations Product Portfolio
- 4.14.5 Aurobindo Pharma Recent Developments
- 4.15 Alkem
- 4.15.1 Alkem Company Information
- 4.15.2 Alkem Business Overview
- 4.15.3 Alkem Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Alkem Finasteride Preparations Product Portfolio
- 4.15.5 Alkem Recent Developments
- 4.16 Accord Healthcare
- 4.16.1 Accord Healthcare Company Information
- 4.16.2 Accord Healthcare Business Overview
- 4.16.3 Accord Healthcare Finasteride Preparations Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Accord Healthcare Finasteride Preparations Product Portfolio
- 4.16.5 Accord Healthcare Recent Developments
5 Global Finasteride Preparations Market Scenario by Region
- 5.1 Global Finasteride Preparations Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Finasteride Preparations Sales by Region: 2021-2032
- 5.2.1 Global Finasteride Preparations Sales by Region: 2021-2026
- 5.2.2 Global Finasteride Preparations Sales by Region: 2027-2032
- 5.3 Global Finasteride Preparations Revenue by Region: 2021-2032
- 5.3.1 Global Finasteride Preparations Revenue by Region: 2021-2026
- 5.3.2 Global Finasteride Preparations Revenue by Region: 2027-2032
- 5.4 North America Finasteride Preparations Market Facts & Figures by Country
- 5.4.1 North America Finasteride Preparations Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Finasteride Preparations Sales by Country (2021-2032)
- 5.4.3 North America Finasteride Preparations Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Finasteride Preparations Market Facts & Figures by Country
- 5.5.1 Europe Finasteride Preparations Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Finasteride Preparations Sales by Country (2021-2032)
- 5.5.3 Europe Finasteride Preparations Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Finasteride Preparations Market Facts & Figures by Country
- 5.6.1 Asia Pacific Finasteride Preparations Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Finasteride Preparations Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Finasteride Preparations Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Finasteride Preparations Market Facts & Figures by Country
- 5.7.1 South America Finasteride Preparations Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Finasteride Preparations Sales by Country (2021-2032)
- 5.7.3 South America Finasteride Preparations Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Finasteride Preparations Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Finasteride Preparations Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Finasteride Preparations Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Finasteride Preparations Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Finasteride Preparations Sales by Type (2021-2032)
- 6.1.1 Global Finasteride Preparations Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Finasteride Preparations Sales Market Share by Type (2021-2032)
- 6.2 Global Finasteride Preparations Revenue by Type (2021-2032)
- 6.2.1 Global Finasteride Preparations Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Finasteride Preparations Revenue Market Share by Type (2021-2032)
- 6.3 Global Finasteride Preparations Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Finasteride Preparations Sales by Application (2021-2032)
- 7.1.1 Global Finasteride Preparations Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Finasteride Preparations Sales Market Share by Application (2021-2032)
- 7.2 Global Finasteride Preparations Revenue by Application (2021-2032)
- 7.2.1 Global Finasteride Preparations Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Finasteride Preparations Revenue Market Share by Application (2021-2032)
- 7.3 Global Finasteride Preparations Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Finasteride Preparations Value Chain Analysis
- 8.1.1 Finasteride Preparations Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Finasteride Preparations Production Mode & Process
- 8.2 Finasteride Preparations Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Finasteride Preparations Distributors
- 8.2.3 Finasteride Preparations Customers
9 Global Finasteride Preparations Analyzing Market Dynamics
- 9.1 Finasteride Preparations Industry Trends
- 9.2 Finasteride Preparations Industry Drivers
- 9.3 Finasteride Preparations Industry Opportunities and Challenges
- 9.4 Finasteride Preparations Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst